Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Oncotarget|December 12, 2013
Adipose-derived Mesenchymal Stem Cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signalingVincenzo Eterno, Alberto Zambelli, Lorenzo Pavesi, et al.
Plos One|January 25, 2015
JAK2 exon 14 skipping in patients with primary myelofibrosis: a minor splice variant modulated by the JAK2-V617F allele burdenPaolo Catarsi, Vittorio Rosti, Giacomo Morreale, et al.
Plos One|August 2, 2019
Constitutive STAT5 phosphorylation in CD34+ cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severityCarlotta Abbà, Rita Campanelli, Paolo Catarsi, et al.
Circulation Research|May 14, 2005
Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptorMarina Cerrone, Barbara Colombi, Massimo Santoro, et al.
Thyroid : Official Journal of the American Thyroid Association|September 10, 2010
Burkitt-like lymphoma infiltrating a hyperfunctioning thyroid adenoma and presenting as a hot noduleAntonella Camera, Flavia Magri, Rodolfo Fonte, et al.
British Journal of Haematology|April 6, 2007
Anaemia characterises patients with myelofibrosis harbouring Mpl mutationPaola Guglielmelli, Alessandro Pancrazzi, Gaetano Bergamaschi, et al.
Genes|August 27, 2021
Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and OutcomesLaura Villani, Adriana Carolei, Vittorio Rosti, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 17, 2013
Type I and type II interferons inhibit both basal and tumor necrosis factor-α-induced CXCL8 secretion in primary cultures of human thyrocytesMario Rotondi, Francesca Coperchini, Riccardo Sideri, et al.
Cytokine|August 31, 2010
Evaluation of the bioactive and total transforming growth factor β1 levels in primary myelofibrosisRita Campanelli, Vittorio Rosti, Laura Villani, et al.
Plos One|April 5, 2013
JAK2 V617F genotype is a strong determinant of blast transformation in primary myelofibrosisGiovanni Barosi, Valentina Poletto, Margherita Massa, et al.
Pageof 8